Please note: due dates differ according to scheme.
- Therapeutic Development Opportunities scheme due 28 November 2018
- Research Grants due 30 January 2019
Awards Available
Therapeutic development opportunities for neuroprotection and neuroregeneration in multiple sclerosis
This supports drug development opportunities for therapies promoting neuroprotection and repair.
- Funding & Duration: up to USD $300,000 (approx. AUD $425,000) per project over one to two years.
- Eligibility: Applications are open to global commercial organisations and non-profit research institutions collaborating with a commercial organisation.
- Visit the website for this scheme
Research Grants
- Funding & Duration: Award amount not supplied. Grants are awarded for 1-5 years.
- Eligibility: Principal investigators may be of any nationality and the sponsoring institution may be in any country permitted by US policies. Institutions, except in unusual circumstances, are the official recipients of grants. Applicants are encouraged to apply for research funding also from local sources.
- Visit the website for this scheme
Submission Requirements & Due Date
- Therapeutic Development Opportunities must be submitted for internal review by 28 November 2018
- Research Grants must be submitted for internal review by 30 January 2019
- Please email rbinternational@adelaide.edu.au if you are considering applying for any of these schemes.
- See also: Submitting an Application to Research Services for Review